WisdomTree BioRevolution Fund (WDNA)

BATS: WDNA · IEX Real-Time Price · USD
+0.52 (3.07%)
Oct 4, 2022 11:15 AM EDT - Market open
Assets n/a
NAV n/a
Expense Ratio n/a
PE Ratio n/a
Shares Out n/a
Dividend (ttm) $0.02
Dividend Yield 0.14%
Ex-Dividend Date n/a
1-Year Return -33.98%
Volume 423
Open 17.51
Previous Close 17.07
Day's Range 17.07 - 17.59
52-Week Low 15.94
52-Week High 26.60
Beta n/a
Holdings n/a
Inception Date Jun 3, 2021

About WDNA

The fund generally uses a representative sampling strategy to achieve its investment objective, meaning it generally will invest in a sample of the securities in the index whose risk, return and other characteristics resemble the risk, return and other characteristics of the Index as a whole. The index is designed to provide exposure to equity securities of exchange listed companies globally that will be significantly transformed by advancements in genetics and biotechnology. The fund is non-diversified.

Stock Exchange BATS
Ticker Symbol WDNA


Ex-Dividend Amount Pay Date
Dec 27, 2021 $0.02458 Dec 30, 2021
Full Dividend History


Biden's “Cancer Moonshot” Brings Biotech Focus Back to U.S.

President Biden spoke at the Kennedy Presidential Library on the 60th anniversary of JFK's moonshot speech on Monday, September 12, outlining his plans for building out American research to end cancer, ...

2 weeks ago - ETF Trends

When Megatrends Intersect, Investors Can Benefit

When it comes to disruptive growth concepts, also known as megatrends, investors frequently focus on these technologies in singular fashion. However, one of the more alluring factors in innovative growt...

Other symbols: WTAI
8 months ago - ETF Trends

Rare Valuation Opportunities Afoot in Some Megatrends ETFs

Equities are off to a dismal start to 2022, with high-growth and technology stocks, particularly shares of unprofitable companies, ranking among the worst offenders.

Other symbols: WCBR
9 months ago - ETF Trends

Top ETFs Tracking CRISPR Gene Editing

These ETFs give you exposure to CRISPR gene editing without having to pick individual stocks.

10 months ago - The Motley Fool

Harness Power, Promise of Genetics Research with WDNA

Genomics represents one of the most disruptive, opportunity-rich investment frontiers, but stock picking in this space is tricky, to say the least. That underscores the utility of various genomics-dedic...

10 months ago - ETF Trends

Historic Opportunity Afoot in Biotech Investing

Some market pundits love clarion calls and hyperbole, but there are times when credibly rare opportunities do emerge. That might be happening today with biotech, genomics, and other next-generation heal...

11 months ago - ETF Trends

As New Healthcare Era Dawns, Consider WDNA

Investors looking for sector-level innovation beyond the technology realm don't need to stretch into unfamiliar territory — healthcare is prime territory for disruptive growth concepts. Several exchange...

1 year ago - ETF Trends

All Aboard for the BioRevolution!

By Jamie Metzl & Jeremy Schwartz, WisdomTree Discussing the investing opportunity of one of the 21st century's defining megatrends  WisdomTree has collaborated with Dr. Jamie Metzl to help create the Wi...

1 year ago - ETF Trends

Embrace WDNA as BioRevolution Gains Momentum

Investors looking for innovative companies and disruptive growth opportunities without excessive exposure to the technology sector would do well to check out healthcare. Arguably, healthcare is the most...

1 year ago - ETF Trends

The WDNA ETF: Investing in Healthcare Innovation

As has been widely noted over the past 18 months, the coronavirus pandemic has accelerated dramatic shifts in a myriad of sectors and industries. One of the obvious members of that group is healthcare.

1 year ago - ETF Trends

The BioRevolution: An ETF That Taps Into Nearly Everything

Exchange traded fund investors should consider the current opportunities in healthcare innovation. In the recent webcast, The Era of Biotech: How Biology Became Technology, Jeremy Schwartz, Executive Vi...

1 year ago - ETF Trends

The Era of Biotech: How Biology Became Technology

First was the industrial revolution, then came the information era with the Internet; next up are genetics and biotechnology. New megatrends help steer the way the global economy develops.

1 year ago - ETF Trends